These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 824896)
21. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children]. Filloy L; Borjas E; Sierra A Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858 [TBL] [Abstract][Full Text] [Related]
22. [Multicenter study on the status of antibiotic and chemotherapy resistance in Switzerland 1979]. Vischer WA; Piguet JD; Pitton JS; Lüthy R; Nicolet J Schweiz Med Wochenschr; 1982 Mar; 112(12):404-10. PubMed ID: 7071561 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of two methods of antibiotic sensitivity test: gel diffusion and automatic method using ABAC apparatus. II. Study on 399 strains isolated in hospital (author's transl)]. Drugeon H; Courtieu AL Ann Biol Clin (Paris); 1978; 36(6):523-6. PubMed ID: 107836 [TBL] [Abstract][Full Text] [Related]
24. [The development of antibiotics resistance among Salmonella bacteria of animal origin in the Federal Republic of Germany and Berlin (West). 6th communication: 1975 Annual report (author's transl)]. Stephan R; Bulling E; Steinbeck A Zentralbl Bakteriol Orig A; 1977; 237(2-3):264-73. PubMed ID: 848213 [TBL] [Abstract][Full Text] [Related]
25. Comparison of three standardized disc susceptibility testing methods for colistin. Tan TY; Ng LS J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528 [TBL] [Abstract][Full Text] [Related]
26. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396 [TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230 [TBL] [Abstract][Full Text] [Related]
28. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp]. Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478 [TBL] [Abstract][Full Text] [Related]
29. [Survey in hospital surroundings on the sensivity to antibiotics of gram-negative bacilli, agents of urinary and enteric infections]. Dammron A Pathol Biol (Paris); 1969 Oct; 17(19):833-8. PubMed ID: 4985139 [No Abstract] [Full Text] [Related]
30. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico. Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermúdez M; Colón M P R Health Sci J; 2003 Sep; 22(3):265-71. PubMed ID: 14619453 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility of "enterobacteria" to aminoglycoside antibiotics: comparisons with tetracyclines, polymyxins, chloramphenicol, and spectinomycin. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Aug; 134 Suppl():S57-74. PubMed ID: 184213 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic susceptibility patterns of selected bacterial isolates in a general hospital in Kuwait. Dhar R; Marafi E J Trop Med Hyg; 1991 Apr; 94(2):111-5. PubMed ID: 2023287 [TBL] [Abstract][Full Text] [Related]
33. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections]. Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174 [TBL] [Abstract][Full Text] [Related]
34. In vitro bacteriological study of a new antibiotic substance: sisomicin. Jedlicková Z; Sulová J Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):104-11. PubMed ID: 809943 [TBL] [Abstract][Full Text] [Related]
35. [Susceptibility and frequency of selected groups of bacteria isolated in 2001 from patients at the Holy Cross Cancer Center]. Durnaś B; Góźdź S; Piestrak E; Zółcińska D; Dzierzanowska D Med Dosw Mikrobiol; 2003; 55(3):285-95. PubMed ID: 14702671 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Moody JA; Gerding DN; Peterson LR Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380 [TBL] [Abstract][Full Text] [Related]
37. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin. Schmalreck AF; Wildfeuer A Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754 [TBL] [Abstract][Full Text] [Related]
39. Development of clinically important resistance to quinolones and other antibiotic groups. Lode H J Int Med Res; 1990; 18 Suppl 4():27D-36D. PubMed ID: 2282967 [TBL] [Abstract][Full Text] [Related]
40. [Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000 - 2001)]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1035-45. PubMed ID: 12899774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]